|Articles|September 23, 2005
BREAKING NEWS: FDA's Crawford Resigns
FDA Commissioner resigns just months after taking on the position.
Advertisement
FDA Commissioner Lester Crawford has resigned his position just two months following his cofirmation by the Senate, according to the Wall Street Journal.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
ACT Brief: Funding Gaps and Indication Decisions in Early-Stage Programs, Recruitment Funnel Leak Diagnosis, and Mega-Merger Speculation Denial
2
ACT Brief: Commercial Strategy Shaping Early Clinical Development, Real-Time Trials Require Operational Infrastructure, and AI Site Engagement Gap
3
Real-Time Trials Need More Than AI: Why Operational Trial Infrastructure Matters
4
FDA Makes Case for Overhauling Early Clinical Development to Reclaim US Leadership
5